StocksDeepDive
Snapshot · All Ordinaries · generated 2026-09-19 21:51 UTC

MYX.AX — Mayne Pharma Group Limited

UNDERVALUED (MOS +47.4%) · Quality 62/100

Price
3.01
Intrinsic value
5.72
Margin of safety
+47.4%
Implied growth (reverse DCF)
-9.3%
model assumes +0.0%
Value Score
44
Quality
62
Psychology
8.5
Discovery
12.1
price/volume attention only
Moat score
54.2
erosion: none

Value Score: top 18% of All Ordinaries · Quality: top 36%

Open the interactive Deep Dive for MYX.AX →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/MYX.AX - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is MYX.AX undervalued?

As of 2026-09-19, MYX.AX trades at 3.01 against a computed intrinsic value of 5.72 (+47.4% margin of safety) - StocksDeepDive's valuation label for this is UNDERVALUED. This is a described calculation from public data, not a recommendation.

What is Mayne Pharma Group Limited's Value Score?

Mayne Pharma Group Limited's Value Score is 44 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.